M019-1857 Screening compound: 4-{4-[5-(2-phenylethyl)-1,2,4-oxadiazol-3-yl]pyridin-2-yl}morpholine

M019-1857 Screening compound: 4-{4-[5-(2-phenylethyl)-1,2,4-oxadiazol-3-yl]pyridin-2-yl}morpholine
M019-1857 Screening compound: 4-{4-[5-(2-phenylethyl)-1,2,4-oxadiazol-3-yl]pyridin-2-yl}morpholine alternative view

Chemical Structure Depiction of ChemDiv screening compound M019-1857
4-{4-[5-(2-phenylethyl)-1,2,4-oxadiazol-3-yl]pyridin-2-yl}morpholine

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

M019-1857

Molecular Formula

C19H20N4O2 (C19 H20 N4 O2)

Compound Name

4-{4-[5-(2-phenylethyl)-1,2,4-oxadiazol-3-yl]pyridin-2-yl}morpholine

IUPAC name

4-{4-[5-(2-phenylethyl)-124-oxadiazol-3-yl]pyridin-2-yl}morpholine

SMILES

C(Cc1ccccc1)c1nc(-c2cc(N3CCOCC3)ncc2)no1

InChI

InChI=1S/C19H20N4O2/c1-2-4-15(5-3-1)6-7-18-21-19(22-25-18)16-8-9-20-17(14-16)23-10-12-24-13-11-23/h1-5,8-9,14H,6-7,10-13H2

InChI Key

IMLWXRCYKRNPPG-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD27492685

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

336.39

Hydrogen Bond Acceptors Count

5.00

Hydrogen Bond Donors Count

0.00

Rotatable Bond Count

5.00

Number of Nitrogen and Oxygen Atoms

6

Partition Coefficient, logP

4.333

Distribution Coefficient, logD

4.333

Water Solubility, LogSw

-4.43

Polar Surface Area

51.182

Acid Dissociation Constant (pKa)

23.71

Base Dissociation Constant (pKb)

4.44

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

31.60

M019-1857 in Drug Discovery

Included in Screening Libraries

Anti-Inflammatory Library (24602 compounds)

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

GPCR Targeted Library (31838 compounds)

SmartTM Library (51161 compounds)

Akt-Targeted Library (14764 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Immune system
  • Musculoskeletal
  • Respiratory tract
  • Nervous system
  • Congenital
  • Skin
  • Metabolic
  • Endocrine
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
Targets:
  • GPCR
  • Kinases
Mechanism of action:
  • Receptor's ligands

References: we are preparing a list of scientific research reports with M019-1857 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound M019-1857?
Check Price and Availability of M019-1857, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of M019-1857 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for M019-1857
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for M019-1857
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of M019-1857 available by request